Skip to main content

Advertisement

Log in

Helicobacter pylori Infection Status Correlates with Serum Parameter Levels Responding to Multi-organ Functions

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Epidemiological studies have demonstrated the relationship between Helicobacter pylori infection and gastric and extra-gastric diseases. Therefore, H. pylori infection might be a “systemic” disease.

Aim

To investigate the relationship between H. pylori infection status and serum parameter levels responding to multi-organ functions.

Methods

A total of 2,044 subjects were selected, including 1,249 males and 795 females with ages ranging from 16 to 86 years. Relevant parameters including blood lipids, complete blood count, tumor markers, indexes of stomach, kidney, liver, thyroid, and immune system function, H.pylori IgG antibody levels, and 14C-UBT were collected.

Results

Serum pepsinogen (PG)I, PGII, and gastrin (G)17 levels were decreased in chronic long-term, past, and acute short-term infection patients compared with uninfected controls. However, the serum PGI/II ratio increased gradually. Serum white blood cell levels gradually decreased in past, chronic long-term, and acute short-term infection patients compared with uninfected controls. The same trend was also observed for CD4+ T cell levels. In addition, LDL levels were higher in chronic long-term infection, HDL levels were lower in past infection, and ALP and CEA levels were higher in acute short-term infection compared with the uninfected group.

Conclusions

Helicobacter pylori infection correlated with increased PGI, PGII, G17, WBC, and CD4+ T cell levels, and decreased PGI/II ratio. In chronic long-term or past infection, H. pylori infection was associated with higher LDL or lower HDL levels. In acute short-term infection, H. pylori infection correlated with higher ALP and CEA levels. H. pylori infection correlated with serum parameter levels responding to multi-organ functions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449–490.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Schottker B, Adamu MA, Weck MN, Muller H, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis. 2012;220:569–574.

    Article  PubMed  Google Scholar 

  3. Jafarzadeh A, Esmaeeli-Nadimi A, Nemati M, Tahmasbi M, Ahmadi P. Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease. East Mediterr Health J. 2010;16:1039–1044.

    CAS  PubMed  Google Scholar 

  4. Park MJ, Choi SH, Kim D, et al. Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population. Gut Liver. 2011;5:321–327.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Kikuchi T, Kobayashi T, Yamashita T, Ohashi K, Sakamaki H, Akiyama H. Eight-year follow-up of patients with immune thrombocytopenic purpura related to H. pylori infection. Platelets. 2011;22:61–64.

    Article  CAS  PubMed  Google Scholar 

  6. Xia W, Zhang X, Wang J, Sun C, Wu L. Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication. Br J Nutr. 2012;108:357–362.

    Article  CAS  PubMed  Google Scholar 

  7. Malik R, Guleria K, Kaur I, Sikka M, Radhakrishnan G. Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy—a pilot study. Indian J Med Res. 2011;134:224–231.

    PubMed Central  PubMed  Google Scholar 

  8. Ben Mahmoud L, Ghozzi H, Hakim A, Sahnoun Z, Zeghal K. Helicobacter pylori associated with chronic urticaria. J Infect Dev Ctries. 2011;5:596–598.

    Article  PubMed  Google Scholar 

  9. Kim JM, Kim SH, Park KH, Han SY, Shim HS. Investigation of the association between Helicobacter pylori infection and normal tension glaucoma. Invest Ophthalmol Vis Sci. 2011;52:665–668.

    Article  PubMed  Google Scholar 

  10. Akashi R, Ishiguro N, Shimizu S, Kawashima M. Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011;38:761–766.

    Article  PubMed  Google Scholar 

  11. Ki MR, Goo MJ, Park JK, et al. Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-beta1-induced inflammatory signaling. Lab Invest. 2010;90:1507–1516.

    Article  CAS  PubMed  Google Scholar 

  12. Silva LD, Rocha AM, Rocha GA, et al. The presence of Helicobacter pylori in the liver depends on the Th1, Th17 and Treg cytokine profile of the patient. Mem Inst Oswaldo Cruz. 2011;106:748–754.

    Article  CAS  PubMed  Google Scholar 

  13. Le Roux-Goglin E, Varon C, Spuul P, Asencio C, Megraud F, Genot E. Helicobacter infection induces podosome assembly in primary hepatocytes in vitro. Eur J Cell Biol. 2012;91:161–170.

    Article  PubMed  Google Scholar 

  14. Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter. 2011;16:65–69.

    Article  PubMed  Google Scholar 

  15. Ataseven H, Demir M, Gen R. Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. South Med J. 2010;103:988–992.

    Article  PubMed  Google Scholar 

  16. Schimke K, Chubb SA, Davis WA, Davis TM. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis. 2010;212:321–326.

    Article  CAS  PubMed  Google Scholar 

  17. Dobbs SM, Dobbs RJ, Weller C, et al. Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic Parkinsonism. Helicobacter. 2010;15:279–294.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Shiota S, Murakami K, Yoshiiwa A, et al. The relationship between Helicobacter pylori infection and Alzheimer’s disease in Japan. J Neurol. 2011;258:1460–1463.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Kountouras J, Zavos C, Boziki M, Gavalas E, Kyriakou P, Deretzi G. Association between Helicobacter pylori infection and Alzheimer’s disease in Japan. J Neurol. 2011;258:2086.

    Article  PubMed  Google Scholar 

  20. Varis K, Kekki M, Harkonen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol. 1991;186:117–123.

    Article  CAS  Google Scholar 

  21. Sipponen P, Valle J, Varis K, Kekki M, Ihamaki T, Siurala M. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol. 1990;25:513–519.

    Article  CAS  PubMed  Google Scholar 

  22. Varis K, Isokoski M. Screening of type A gastritis. Ann Clin Res. 1981;13:133–138.

    CAS  PubMed  Google Scholar 

  23. Sun LP, Gong YH, Wang L, Yuan Y. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. World J Gastroenterol. 2007;13:6562–6567.

    Article  CAS  PubMed  Google Scholar 

  24. Chimienti G, Russo F, Lamanuzzi BL, et al. Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a). Clin Biochem. 2003;36:359–365.

    Article  CAS  PubMed  Google Scholar 

  25. Chen Y, Blaser MJ. Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis. 2012;205:1195–1202.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Ohkusa T, Miwa H, Nomura T, et al. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Aliment Pharmacol Ther. 2004;20:25–32.

    Article  PubMed  Google Scholar 

  27. Samloff IM, Liebman WM. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology. 1973;65:36–42.

    CAS  PubMed  Google Scholar 

  28. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut. 2002;50:13–18.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Samloff IM. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology. 1971;61:185–188.

    CAS  PubMed  Google Scholar 

  30. Karttunen TJ, Niemela S, Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig Dis. 1996;41:1332–1336.

    Article  CAS  Google Scholar 

  31. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol. 2001;166:7456–7461.

    Article  CAS  PubMed  Google Scholar 

  32. Lundgren A, Trollmo C, Edebo A, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4 + T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun. 2005;73:5612–5619.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci. 2005;50:1228–1231.

    Article  CAS  PubMed  Google Scholar 

  34. Satoh H, Saijo Y, Yoshioka E, Tsutsui H. Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb. 2010;17:1041–1048.

    Article  CAS  PubMed  Google Scholar 

  35. Jia EZ, Zhao FJ, Hao B, et al. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis. 2009;8:59.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Kucukazman M, Yavuz B, Sacikara M, et al. The relationship between updated Sydney System score and LDL cholesterol levels in patients infected with Helicobacter pylori. Dig Dis Sci. 2009;54:604–607.

    Article  CAS  PubMed  Google Scholar 

  37. Taylor IL, Byrne WJ, Christie DL, Ament ME, Walsh JH. Effect of individual l-amino acids on gastric acid secretion and serum gastrin and pancreatic polypeptide release in humans. Gastroenterology. 1982;83:273–278.

    CAS  PubMed  Google Scholar 

  38. Russo F, Jirillo E, Clemente C, et al. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol. 2001;23:13–24.

    Article  CAS  PubMed  Google Scholar 

  39. Ramharack R, Barkalow D, Spahr MA. Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol. 1998;18:984–990.

    Article  CAS  PubMed  Google Scholar 

  40. Pike AF, Kramer NI, Blaauboer BJ, Seinen W, Brands R. A novel hypothesis for an alkaline phosphatase ‘rescue’ mechanism in the hepatic acute phase immune response. Biochim Biophys Acta. 2013;1832:2044–2056.

  41. Yu H, Yu TN, Cai XJ. Tumor biomarkers: help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5. Chin Med J (Engl). 2013;126:3044–3047.

  42. Hiew C, Duggan A, de Malmanche T, et al. Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention. Intern Med J. 2012;42:289–293.

    Article  CAS  PubMed  Google Scholar 

  43. Sterzl I, Hrda P, Matucha P, Cerovska J, Zamrazil V. Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res. 2008;57:S135–S141.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by the National Basic Research Development Program of China (973 Program No. 2010CB529304) and National Natural Science Foundation of China (No. 31000074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuan Yuan.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 34 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, Y., Wei, W., Jingwei, L. et al. Helicobacter pylori Infection Status Correlates with Serum Parameter Levels Responding to Multi-organ Functions. Dig Dis Sci 60, 1748–1754 (2015). https://doi.org/10.1007/s10620-015-3522-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3522-2

Keywords

Navigation